Search

GA in Practice Background

Editorial Feature:

GA in Practice

How data and personal experience are evolving the treatment of geographic atrophy.

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Show Description +

How can clinicians counsel patients with aggressive, bilateral geographic atrophy who present with good vision despite high-risk imaging biomarkers? And what do you do when they become monocular during treatment? In this episode of GA in Practice, Geeta Lalwani, MD, presents a real-world case to panelists Murtaza Adam, MD, and Carl Danzig, MD. The group reviews treatment interval preferences and management of concurrent wet AMD in a long-term complement inhibition patient such as the one Dr. Lalwani presents.

Posted: 7/01/2026

Keywords:

Geographic Atrophy (GA)

•

Monocular

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

•

Macular Degeneration

•

Patient Education

•

bilateral

•

Biomarkers

•

risk

•

concurrent

•

complement inhibition

•

complement factors

Up Next

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Multimodal Imaging for Biomarker Detection in GA Patients

Multimodal Imaging for Biomarker Detection in GA Patients

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Why Retina Specialists Are Growing More Comfortable With Early Treatment

Why Retina Specialists Are Growing More Comfortable With Early Treatment

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Talking to Patients About Treatment Risks

Talking to Patients About Treatment Risks

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA in the Presence of Dense Cataract, Followed by CNV Development

GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Delayed Complement Inhibition Therapy per Patient Request

Delayed Complement Inhibition Therapy per Patient Request

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Back to All Videos

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

How can clinicians counsel patients with aggressive, bilateral geographic atrophy who present with good vision despite high-risk imaging biomarkers? And what do you do when they become monocular during treatment? In this episode of GA in Practice, Geeta Lalwani, MD, presents a real-world case to panelists Murtaza Adam, MD, and Carl Danzig, MD. The group reviews treatment interval preferences and management of concurrent wet AMD in a long-term complement inhibition patient such as the one Dr. Lalwani presents.

Posted: 7/01/2026

Keywords:

Geographic Atrophy (GA)

•

Monocular

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

•

Macular Degeneration

•

Patient Education

•

bilateral

•

Biomarkers

•

risk

•

concurrent

•

complement inhibition

•

complement factors

Please log in to leave a comment.